Breaking News

Par Pharma Appoints Commercial Officer

By Kristin Brooks | February 21, 2014

JHP’s Pera brings more than 30 years of industry experience

Antonio R. Pera has been named chief commercial officer at Par Pharmaceutical Companies. Mr. Pera will lead Par's newly-integrated sales and marketing organization following its acquisition of JHP Pharmaceuticals, and will manage relationships with its major trade partners.
 
Mr. Pera was previously with JHP, where he served as senior vice president, commercial operations. He has more than 30 years of experience in the pharma industry, including manufacturing and wholesale for generic and branded products. Prior to JHP, Mr. Pera was senior vice president, supply chain management at AmerisourceBergen Corp., where he served as a corporate officer and led the procurement function.
 
"Tony has enjoyed a distinguished career in the pharmaceutical industry and we are very pleased to have him join the Par team," said Paul V. Campanelli, chief executive officer of Par Pharmaceutical Companies. "He has a demonstrated expertise in the marketing, sales and distribution of generic drugs. We look forward to the leadership Tony will provide our commercial organization and the many contributions he will make to our company."

Related Packaging:

Related Contract Manufacturing:

Related Compliance:

blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.